Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...
A new study found a strong connection between azathioprine exposure and development of ICP in women with systemic lupus erythematosus (SLE).
Existing evidence suggests genetics, environmental factors, and exposure to specific chemicals—such as those in cigarettes—can all increase a person’s risk of systemic lupus erythematosus. Systemic ...
Objectives Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) are associated with improved ...
Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers studied ...
“Treatments for discoid lupus erythematosus often focus on addressing skin symptoms over known systemic complications, such ...
Adverse drug effects among patients under treatment for autoimmune rheumatologic disorders stemmed more often from ancillary medications -- and not necessarily prescription products -- than from ...
GlobalData on MSN
FDA approves AstraZeneca’s Saphnelo for SLE
The approval is supported by results from the Phase III TULIP-SC trial.
Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...
Black women are three times more likely to be diagnosed with systemic lupus erythematosus (SLE), the most common form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results